Literature DB >> 12454417

Role of mechanics in vascular tissue engineering.

Robert M Nerem1.   

Abstract

There is a clinical need for the tissue engineering of a small diameter blood vessel substitute. Ideally such a vascular substitute should possess the functional attributes of the native vessel which it will replace. This means not only having the appropriate mechanical properties, but also being non-thrombogenic and exhibiting vasoactivity. In each of these there is in some way a role of mechanics. For thrombogenicity, an "endothelial-like" lining is required, one which is responsive to its mechanical environment in a manner similar to that of the normal vascular endothelium. If vasoactivity is exhibited, then this lining must also serve as a signal transduction interface, communicating with the underlying smooth muscle cells which themselves must be of a contractile phenotype if they are to carry out the biomechanical function resulting in contraction and dilation. Having appropriate mechanical properties means not only exhibiting sufficient strength, but also a viscoelasticity which allows for a compliance that matches that of the vascular system into which the vascular substitute is to be placed. Finally, once implanted the biological responses which will occur at least in part are regulated by biomechanical factors. Thus, the proper incorporation of biomechanics into the design of a vascular substitute is critical to achieving success.

Mesh:

Year:  2003        PMID: 12454417

Source DB:  PubMed          Journal:  Biorheology        ISSN: 0006-355X            Impact factor:   1.875


  15 in total

Review 1.  Twisted blood vessels: symptoms, etiology and biomechanical mechanisms.

Authors:  Hai-Chao Han
Journal:  J Vasc Res       Date:  2012-03-14       Impact factor: 1.934

2.  Repeated rapid shear-responsiveness of peptide hydrogels with tunable shear modulus.

Authors:  Sivakumar Ramachandran; Yiider Tseng; Y Bruce Yu
Journal:  Biomacromolecules       Date:  2005 May-Jun       Impact factor: 6.988

3.  Biomechanical effects of flow and coculture on human aortic and cord blood-derived endothelial cells.

Authors:  Li Cao; Andrew Wu; George A Truskey
Journal:  J Biomech       Date:  2011-06-16       Impact factor: 2.712

Review 4.  [Tissue engineering for heart valves and vascular grafts].

Authors:  O E Teebken; M Wilhelmi; A Haverich
Journal:  Chirurg       Date:  2005-05       Impact factor: 0.955

5.  A triphasic constrained mixture model of engineered tissue formation under in vitro dynamic mechanical conditioning.

Authors:  Joao S Soares; Michael S Sacks
Journal:  Biomech Model Mechanobiol       Date:  2015-06-09

6.  Improved recellularization of ex vivo vascular scaffolds using directed transport gradients to modulate ECM remodeling.

Authors:  Zehra Tosun; Peter S McFetridge
Journal:  Biotechnol Bioeng       Date:  2013-04-29       Impact factor: 4.530

7.  Angiogenic microenvironment augments impaired endothelial responses under diabetic conditions.

Authors:  Abdul Q Sheikh; Courtney Kuesel; Toloo Taghian; Jennifer R Hurley; Wei Huang; Yigang Wang; Robert B Hinton; Daria A Narmoneva
Journal:  Am J Physiol Cell Physiol       Date:  2014-02-26       Impact factor: 4.249

8.  Small-diameter biodegradable scaffolds for functional vascular tissue engineering in the mouse model.

Authors:  Jason D Roh; Gregory N Nelson; Matthew P Brennan; Tamar L Mirensky; Tai Yi; Tyrone F Hazlett; George Tellides; Albert J Sinusas; Jordan S Pober; W M Saltzman; Themis R Kyriakides; Christopher K Breuer
Journal:  Biomaterials       Date:  2007-12-27       Impact factor: 12.479

9.  Pilot assessment of a human extracellular matrix-based vascular graft in a rabbit model.

Authors:  Salma Amensag; Leslie Goldberg; Kerri A O'Malley; Demaretta S Rush; Scott A Berceli; Peter S McFetridge
Journal:  J Vasc Surg       Date:  2016-04-29       Impact factor: 4.268

10.  Decoupling cell and matrix mechanics in engineered microtissues using magnetically actuated microcantilevers.

Authors:  Ruogang Zhao; Thomas Boudou; Wei-Gang Wang; Christopher S Chen; Daniel H Reich
Journal:  Adv Mater       Date:  2013-01-28       Impact factor: 30.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.